期刊文献+

天然植物药肝脏内DNA加合物的研究进展

Advances in research on DNA adducts in liver of natural botanicals
原文传递
导出
摘要 天然药物包括植物药、动物药和海洋药物,在我国天然植物药的使用有悠久的历史。但是随着现代科学技术的发展,马兜铃酸肾病的发现,人们逐渐对天然植物药的安全性产生了怀疑。此后多年,陆续从天然植物药中分离了多种有肝肾毒性的化合物。重点围绕已知的化合物代谢形成DNA加合物的过程阐述天然植物药致突变致癌分子机制的研究进展。 Natural medicines include botanicals, animal medicines and marine medicines. In China, there is a long history of the use of natural botanicals. However, with the development of modern science and technology, the discovery of aristolochic acid nephropathy, people have gradually doubted the safety of natural botanical drugs. Since then, many compounds with liver and kidney toxicity have been isolated from natural botanicals. This paper focuses on the research progress of molecular mechanisms of mutagenic carcinogenesis of natural botanicals by the process of known compound metabolism in the form of DNA adducts.
作者 夏彤 XIA Tong(Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China)
出处 《药物评价研究》 CAS 2019年第1期216-222,共7页 Drug Evaluation Research
关键词 天然植物药 DNA加合物 致突变 遗传毒性 natural botanicals DNA adduct mutagenic genotoxicity
  • 相关文献

参考文献16

二级参考文献183

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部